期刊文献+

TNFAIP8干扰质粒的构建及最佳干扰效率质粒的筛选 被引量:1

Construction and identification of interference plasmid targeting on TNFAIP8
下载PDF
导出
摘要 目的:构建并筛选出干扰效率最佳的TNFAIP8-shRNA-p SIREN-Retro Q干扰质粒。方法:通过生物软件选择3个TNFAIP8基因干扰位点,构建干扰质粒并测序验证,将干扰质粒及对照质粒分别转染至A549细胞,通过RT-PCR、Western blot检测干扰效率。结果:经RT-PCR和Western-Blot证实TNFAIP8-shRNA-p SIREN-Retro Q干扰质粒能有效干扰并抑制细胞内TNFAIP8基因的表达,通过流式检测发现降低TNVAIP8表达可以提高细胞对a DR5Sc Fv诱导凋亡的敏感性。结论:成功构建和设计了对TNFAIP8基因具有显著干扰效率的干扰质粒,为进一步研究TNFAIP8基因的功能奠定了基础。 Objective: To construct and screen the high efficiency interference plasmid of TFAIP8-shRNA-pSIREN- RetroQ. Methods: Selected and synthesized three Target Sequence of TNFAIP8 shRNA1, TNFAIP8 shRNA2, TNFAIP8 shRNA3, and construct the TNFAIP8 interference plasmid. Transfection TNFAIP8-shRNA-pSIREN-RetroQ interference plasmid to A549 cells. Filter out the highest interference efficiency plasmid by detecting the mRNA and protein levels using RT-PCR and Western blot methods. Results: We successfully design and built three TNFAIPS-shRNA-pSIREN -RetroQ interference plasmids,and screen out the highest efficiency interference plasmid. Conclusion: Three interference plasmids targeting the TNFAIP8 gene have been constructed successfully and provide a useful tool for studying the function of TNFAIP8.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第5期650-654,共5页 Chinese Journal of Immunology
基金 国家自然科学基金项目(81272720) 福建省卫计委医学创新课题(2014-CXB-43) 厦门市科技计划项目(3502Z2083008)资助
关键词 TNFAIP8 RNA干扰 重组质粒 筛选 TNFAIP8 RNA interference Recombinant plasmid Screen
  • 相关文献

参考文献14

  • 1Zhang X, Wang J, Fan C, et al. Crystal structure of TNFAIP82 provides insights into immune homeostasis [ J ]. Nat Struct Mol Biol,2009,16 ( 1 ) :89-90.
  • 2Patel S,Wang FH,Whiteside TL,et al. Identification of seven dif- ferentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: im- plications in metastasis and/or radiation rosponse[ J]. Oral Oncol, 1997,33(3) :197-203.
  • 3Kumar D, Gokhale P, Broustas C, et al. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells[ J ]. Oneogene, 2004, 23(2) :612-616.
  • 4Zhang S, Zhang Y, Wei X, et al. Expression and regulation of a novel identified TNFAII~8 family is associated with diabetic nephropathy [ J 1. Biochim Biophys Acta, 2010, 1802 ( 11 ) : 1078-1086.
  • 5Liu T, Gao H, Yang M, et a/. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer [ J ]. Turnout Biol, 2014,35 ( 6 ) : 5805-5814.
  • 6Yang M, Zhao Q, Wang X, et al. TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma [ J ]. Histopathology, 2014, 65(4) :517-526.
  • 7Liu T, Xia B, Lu Y, et al. TNFAIP8 overexpression is associated with platinum resistance in epithelial ovarian cancers with optimal cytoreduction [ J 1. Hum Pathol,2014,45 (6) : 1251-1257.
  • 8ILl lia Pak, A ndr~w F. Distinct populations of primary and secondary effectors during RNAi in C. elegans[ J]. Science ,2007, 315:241-244.
  • 9孟庆宇,程小峰,张佳锴,黄小平,庄国洪.抗人DR5单链抗体诱导HepG2细胞凋亡的实验研究[J].免疫学杂志,2010,26(7):585-588. 被引量:3
  • 10孟庆宇,程晓峰,张佳锴,庄国洪.抗人死亡受体5单链抗体ZF1对鼠H22肝癌细胞的作用分析[J].中国免疫学杂志,2010,26(9):801-805. 被引量:3

二级参考文献35

  • 1杨东海,庄国洪,刘忠臣,张长弓,何琼,李文珠.抗人DR5单克隆抗体的制备、鉴定及活性分析[J].免疫学杂志,2009,25(6):671-675. 被引量:4
  • 2RaymondADANIELS,HelenTURLEY,FionaCKIMBERLEY,XueSongLIU,JuthathipMONGKOLSAPAYA3,PaulCH'EN,XiaoNingXU,BoquanJIN,FrancescoPEZZELLA,GavinRSCREATON.Expression of TRAIL and TRAIL receptors in normal and malignant tissues[J].Cell Research,2005,15(6):430-438. 被引量:22
  • 3李淑莲,马远方,刘广超,张军,白慧玲,刘英杰,卢峰.抗人DR5单克隆抗体mDRA-6对HL-60细胞的诱导凋亡作用[J].免疫学杂志,2007,23(3):295-297. 被引量:5
  • 4Elbashir SM,Harborth J,Lendeckel W,Yalcin A,Weber K,Tuschl T.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411(6836):494.
  • 5Visser HP,Gunster MJ,Kluin-Nelemans HC,et al.The Polycomb group protein EZH2 is upregulated in proliferating,cultured human mantle cell lymphoma[J].Br J Haematol,2001,112(4):950.
  • 6Varambally S,Dhanasekaran SM,Zhou M,et al.The polycomb group protein EZH2 is involved in progression of prostate cancer[J].Nature,2002,419(6907):624.
  • 7Kleer CG,Cao Q,Varambally S,et al.EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells[J].Proc Natl Acad Sci U S A,2003,100(20):11606.
  • 8Sudo T,Utsunomiya T,Mimori K,et al.Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma[J].Br J Cancer,2005,92(9):1754.
  • 9Matsukawa Y,Semba S,Kato H,Ito A,Yanagihara K,Yokozaki H.Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer[J].Cancer Sci,2006,97(6):484.
  • 10Cao R,Wang L,Wang H,et al.Role of histone H3 lysine 27 methylation in Polycomb-group silencing[J].Science,2002,298(5595):1039.

共引文献4

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部